BIOLASE To Participate In H.C. Wainwright Investor Conference
BIOLASE, the global leader in dental lasers, announced that CEO John Beaver will provide an overview of the company at the H.C. Wainwright Global Life Sciences Investor Conference on March 9-10, 2021. The presentation will highlight recent progress and achievements. Investors can schedule one-on-one meetings with BIOLASE executives. The formal presentation will be available on the company’s investor relations webpage. BIOLASE is known for its innovative laser systems, having sold over 41,200 systems worldwide, enhancing dental care with patented technologies.
- None.
- None.
FOOTHILL RANCH, Calif., Feb. 24, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, will be providing an overview of the Company, as well as recent progress and achievements at the H.C. Wainwright Global Life Sciences Investor Conference, which is being held virtually March 9 - 10, 2021.
The conference will feature virtual one-on-one meetings with the BIOLASE executives and institutional investors are invited to request meeting times at tkehrli@evcgroup.com or through their H.C. Wainwright representative. The formal, pre-recorded, presentation will be available in the investor relations section of BIOLASE's website at www.biolase.com.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-to-participate-in-hc-wainwright-investor-conference-301234380.html
SOURCE BIOLASE, Inc.
FAQ
When is the H.C. Wainwright Global Life Sciences Investor Conference where BIOLASE will participate?
Who is presenting for BIOLASE at the H.C. Wainwright Conference?
How can investors schedule meetings with BIOLASE executives during the conference?
Where can I view BIOLASE's presentation after the investor conference?
What notable achievements will BIOLASE discuss at the conference?
